All terms in GO
| Label | Id | Description |
|---|---|---|
| epithelial cell type specification, open tracheal system | GO_0035153 | [Allocation of epithelial cells within each migrating branch in an open tracheal system to distinct tracheal cell fates. During the migration phase each branch forms a well-defined number of cell types (including fusion cells, terminal cells and branch cells) at precise positions.] |
| positive regulation by symbiont of host apoptotic process | GO_0052151 | [Any process in which an organism activates, maintains or increases the frequency, rate or extent of programmed cell death in the host, where programmed cell death proceeds by apoptosis. The host is defined as the larger of the organisms involved in a symbiotic interaction.] |
| maternal process involved in parturition | GO_0060137 | [A reproductive process occurring in the mother that results in birth.] |
| parturition | GO_0007567 | [The reproductive process in which the parent is separated from its offspring either by giving birth to live young or by laying eggs.] |
| regulation of tube size, open tracheal system | GO_0035151 | [Ensuring that an epithelial tube in an open tracheal system is of the correct length and diameter. Tracheal tubes undergo highly regulated tube-size increases during development, expanding up to 40 times their initial size by the end of larval life. Tube size appears to be controlled by regulation of apical membrane expansion and secretion, rather than by changes in cell number, size or shape.] |
| fetal process involved in parturition | GO_0060138 | [A reproductive process occurring in the embryo that results in birth.] |
| positive regulation of antibody-dependent cellular cytotoxicity | GO_0001815 | [Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.] |
| regulation of antibody-dependent cellular cytotoxicity | GO_0001813 | [Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.] |
| antibody-dependent cellular cytotoxicity | GO_0001788 | [Cytolysis of target cells by natural killer cells, eosinophils, neutrophils, monocytes, or macrophages following engagement of antibodies bound to the target cells by Fc receptors on the effector cells.] |
| FYXD domain binding | GO_0098750 | [Interacting selectively and non-covalently with a FXYD domain.] |
| negative regulation of antibody-dependent cellular cytotoxicity | GO_0001814 | [Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.] |
| negative regulation of type I hypersensitivity | GO_0001811 | [Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.] |
| regulation of type I hypersensitivity | GO_0001810 | [Any process that modulates the frequency, rate, or extent of type I hypersensitivity, a type of inflammatory response.] |
| negative regulation of hypersensitivity | GO_0002884 | [Any process that stops, prevents, or reduces the frequency, rate, or extent of hypersensitivity.] |
| type I hypersensitivity | GO_0016068 | [An inflammatory response driven by antigen recognition by antibodies bound to Fc receptors on mast cells or basophils, occurring within minutes after exposure of a sensitized individual to the antigen, and leading to the release of a variety of inflammatory mediators such as histamines.] |
| integral component of the cytoplasmic side of the plasma membrane | GO_0098752 | [The component of the plasma membrane consisting of the gene products that penetrate only the cytoplasmic side of the membrane.] |
| positive regulation of type I hypersensitivity | GO_0001812 | [Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response.] |
| positive regulation of hypersensitivity | GO_0002885 | [Any process that activates or increases the frequency, rate, or extent of hypersensitivity.] |
| anchored component of the cytoplasmic side of the plasma membrane | GO_0098753 | [The component of the plasma membrane consisting of gene products and protein complexes with covalently attached hydrophobic anchors products that penetrate only the cytoplasmic side of the membrane.] |
| regulation of hypersensitivity | GO_0002883 | [Any process that modulates the frequency, rate, or extent of hypersensitivity.] |